Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer

Clinical trial NCT01731652 · COMPLETED

Trial details

NCT number: NCT01731652
Sponsor: Telormedix SA
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma in Situ Non Muscle Invasive Bladder Cancer

Start date: 2013-02-01
Primary completion: 2014-02-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.